Literature - Publication Review

Clinically translatable cytokine delivery platform for eradication of intraperitoneal tumors

clinically-translatable512

Proinflammatory cytokine interleukin-2 (IL-2) is of particular interest for cancer immunotherapy as it plays a critical role in the regulation of immune cells such as T cells. Although proinflammatory cytokines have been used to treat various cancers including metastatic melanoma and renal carcinomas, it has a short blood half-life and the high-dose infusion regimens required result in off-target effects and toxicity in patients.

Read this publication review to learn how researchers used a clinically translatable cytokine delivery platform in an ovarian mouse model validated using non-invasive, longitudinal in vivo optical imaging.

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

Clinically translatable cytokine delivery platform for eradication of intraperitoneal tumors

Download Literature - Publication Review